Opioids in treatment respiratory overdrive in patient with COVID-19 induced ARDS

O. Boduliev (Poltava, Ukraine), N. Adamchuk (Poltava, Ukraine)

Source: Respiratory Failure and Mechanical Ventilation Conference 2022 - Opening session: Essentials of respiratory physiology - Assessment of respiratory muscle function - Pulmonary infections in mechanically ventilated patients - Telemonitoring of patients with chronic respiratory failure - Diagnostics and interventions - Acute respiratory failure: COVID-19 - Interstitial lung disease and pulmonary hypertension - Early rehabilitation - Acute respiratory failure: Invasive mechanical ventilation - HFNO and NIV for acute hypoxemic failure - Longterm NIV miscellaneous - Controversies in acute respiratory failure - The role of respiratory muscle dysfunction in weaning failure - Transitions in chronic NIV - New insights in weaning from invasive ventilation - Noninvasive ventilation (NIV) in the clinical practice: How do I do it? - Difficult weaning from mechanical ventilation - Chronic ventilatory support in different diseases: Is one way fitting all? - Strategies to optimise early mobilisation and rehabilitation in intensive care - Noninvasive ventilation (NIV) in the clinical practice: How do I do it? - Acute respiratory failure: Hypercapnic and diagnosis - Weaning from mechanical ventilation - Mechanical ventilation in the acute setting - Health-related quality of life in mechanical ventilation - Long-term noninvasive ventilation: Diagnosis and outcome - Long-term noninvasive ventilation: Outcome - Acute respiratory failure: Physiology
Session: Acute respiratory failure: Physiology
Session type: Oral poster discussion
Number: 134

Congress or journal article abstractWebcastPDF journal article, handout or slidesE-poster

Abstract

In some patients with COVID – 19 caused ARDS, the symptoms of respiratory failure preserv iven with adequate oxygenation. Forced breathing due to "air hunger" can lead to Patient self-inflicted lung injury. Correction of the "air hunger" by increasing the support pressure leads to an increased risk of lung damage and air leakage syndrome. An alternative may be pharmacological reduction of respiratory drive.

Methods: The two-center randomized cohort study included 79 patients with nasal swab PCR confirmed COVID-19. All patients were treated with NIV and  had “air hunger” and SaO2> 80 mm Hg.

Group 1 - 40 patients. Respiratory overdrive was corrected by increasing the pressure support by 2 cm H2O every 5 minutes to the correction of "air hunger".

Group 2 - 39 patients. IV morphine boluses 5 mg were obtained to reduce respiratory drive.

The results: there were no statistical differences in age, gender and comorbidities of the group. Indicators of respiratory mechanics are presented in table 1.

Group 1 Group 2
Ve, ml/kg 12.2 [11.4 – 13.0] 6.67 [6.04 – 7.29]
MV, l/min 20.9 [19.9 – 21.8] 12.6 [11.4 – 13.8]
PS, mbar 13.2 [12.3 – 14.0] 4.17 [3.7 – 4.6]
FiO2 0.73 [0.67 – 0.79] 0.71 [0.64 – 0.78]

The frequency of failures and complications of respiratory support are presented in table 2.

Group 1 Group 2
NIV failure 9 4
Subcutaneous emphysema 10 2
Pneumothorax 6 1

OR of NIV failure was 0.39 [CI 0.11 - 1.4], OR of subcutaneous emphysema 6.17 [CI 1.25 - 30.32] and OR of pneumothorax 6.70 [CI 0.79 - 58.56].

Conclusions: pharmacological reduction of respiratory owerdrive reduces the likelihood of respiratory complications in patients with COVID-19-induced ARDS.



Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
O. Boduliev (Poltava, Ukraine), N. Adamchuk (Poltava, Ukraine). Opioids in treatment respiratory overdrive in patient with COVID-19 induced ARDS. Respiratory Failure and Mechanical Ventilation Conference 2022 - Opening session: Essentials of respiratory physiology - Assessment of respiratory muscle function - Pulmonary infections in mechanically ventilated patients - Telemonitoring of patients with chronic respiratory failure - Diagnostics and interventions - Acute respiratory failure: COVID-19 - Interstitial lung disease and pulmonary hypertension - Early rehabilitation - Acute respiratory failure: Invasive mechanical ventilation - HFNO and NIV for acute hypoxemic failure - Longterm NIV miscellaneous - Controversies in acute respiratory failure - The role of respiratory muscle dysfunction in weaning failure - Transitions in chronic NIV - New insights in weaning from invasive ventilation - Noninvasive ventilation (NIV) in the clinical practice: How do I do it? - Difficult weaning from mechanical ventilation - Chronic ventilatory support in different diseases: Is one way fitting all? - Strategies to optimise early mobilisation and rehabilitation in intensive care - Noninvasive ventilation (NIV) in the clinical practice: How do I do it? - Acute respiratory failure: Hypercapnic and diagnosis - Weaning from mechanical ventilation - Mechanical ventilation in the acute setting - Health-related quality of life in mechanical ventilation - Long-term noninvasive ventilation: Diagnosis and outcome - Long-term noninvasive ventilation: Outcome - Acute respiratory failure: Physiology

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.